The new impact factor has arrived: who cares? by De Sutter, An et al.
Full Terms & Conditions of access and use can be found at
http://www.tandfonline.com/action/journalInformation?journalCode=igen20
Download by: [Howest] Date: 12 October 2015, At: 00:08
European Journal of General Practice
ISSN: 1381-4788 (Print) 1751-1402 (Online) Journal homepage: http://www.tandfonline.com/loi/igen20
The new impact factor has arrived. Who cares?
An De Sutter, Mieke van Driel, Manfred Maier & Jan De Maeseneer
To cite this article: An De Sutter, Mieke van Driel, Manfred Maier & Jan De Maeseneer (2015)
The new impact factor has arrived. Who cares?, European Journal of General Practice, 21:3,
153-154, DOI: 10.3109/13814788.2015.1070141
To link to this article:  http://dx.doi.org/10.3109/13814788.2015.1070141
Published online: 17 Sep 2015.
Submit your article to this journal 
Article views: 67
View related articles 
View Crossmark data
 Editorial 
 The new impact factor has arrived. Who cares? 
 Last June, the  European Journal of General Practice (EJGP) 
was proud to announce that its impact factor rose to 
1.217, an increase of no less than 50%. This results in 
a steep climb in its rank of primary care journals from 
position 16/18 to position 11/19. This is good news, as 
the  European Journal of General Practice may expect that 
a higher impact factor will attract better papers, will 
increase the status of the journal and will improve its sci-
entiﬁ c credibility internationally (1). It makes this journal 
a more attractive option to be considered by authors for 
whom the impact factor is an important element in their 
choice of a journal to which they submit their work. 
Finally yet importantly, it will please the publisher of the 
 European Journal of General Practice , who will eagerly 
use this milestone in its public relations and marketing 
campaigns. Yet, this event arouses ambiguous feelings. 
 Judged by the level of anxiety with which editors and 
authors look out for this magic number every year, the 
journal impact factor (JIF) still ﬁ rmly stands on its high 
pedestal, in spite of the critiques it has received over the 
past decades (2). The JIF is based on the assumption that 
 ‘ scientiﬁ c impact ’ can be measured as a function of the 
citations that a publication receives. Hitherto, journals 
publishing (some) articles that are much cited are sup-
posed to have more  ‘ impact. ’ Yet, the JIF is nothing more 
than a simple ratio indicating how often papers in a par-
ticular journal have been cited in a selected group of 
journals during a limited period. 
 The word  ‘ selected ’ is particularly meaningful here 
and points to an important limitation: only the journals 
indexed in the Science Citation Index compiled by the 
private company Thomson Reuters are considered. They 
represent only a fraction of the total scientiﬁ c output. In 
this database,  ‘ primary healthcare ’ represents a small 
subject category of 19 journals, including one journal on 
sports medicine. A quick search in Medline — a univer-
sally used index of medical journals maintained by an 
American governmental organization — shows that there 
are many more journals with either  ‘ primary care ’ or 
 ‘ family medicine ’ or  ‘ general practice ’ in their name. 
However, citations in these journals will not aﬀ ect the 
JIF; neither will citations in non-primary care journals 
that are not indexed in the Science Citation Index. 
 Then, let us have a closer look at the calculation of 
the JIF. The 2014 JIF of the  European Journal of General 
Practice equals the number of citations in 2014 of papers 
it published in 2012 and 2013 divided by the number of 
articles it published in 2012 and 2013. In the denomina-
tor, Thomson Reuters counts the number of  ‘ citable 
items ’ i.e.  ‘ a collection of items that are likely to inﬂ u-
ence the scholarly literature ’ (original papers, reviews, 
and proceedings). The company uses a set of criteria to 
establish  ‘ citability ’ (e.g. presence of a summary, the 
number of citations, length of the paper etc.) (3). Regard-
less of whether these criteria eﬀ ectively select the inﬂ u-
ential papers, it is obvious that the mere number of 
papers that are selected is crucial. Variability or lack of 
clarity in the selection criteria can have a substantial 
impact on the outcome of the calculation. By contrast, 
the numerator is much less selective and includes  ‘ any 
citation to the journal ’ , including letters-to-the-editor 
and editorials (4). 
 One can easily see how this number can be inﬂ u-
enced by authors and editors (5). For instance, if 
we would cite two papers of the  European Journal of 
General Practice from the previous year in this 
editorial, it inﬂ uences the next impact factor: the 
numerator would increase with two citations while the 
denominator stays unchanged because an editorial 
is not counted as  ‘ citable ’ . Furthermore, a few highly 
cited papers can substantially increase the numerator 
and thus the JIF: if the  European Journal of General 
Practice had published one paper in 2012 and one in 
2013, each cited 100 times in 2014, our JIF would 
now be 4.6 with the same level of citations for the 
58 other papers in the two publication years. 
 Finally, the formula ties the  ‘ citable period ’ down to 
two years, favouring fast moving research ﬁ elds such as 
molecular biology but impairing areas such as clinical 
medicine and epidemiology, which generally publish 
data from long-term studies (1). Therefore, JIFs of vari-
ous subject categories cannot easily be compared. 
 Thomson Reuters meets some of these critiques by 
providing additional citation data in the Journal Citation 
Reports (JCR), including the JIF without self-citations and 
the ﬁ ve-year impact factor. For example, the  European 
Journal of General Practice 2014 JIF without self-cites is 
1.150, and its ﬁ ve-year JIF is 1.169. They also provide 
data comparing and summarizing all journals in a par-
ticular subject category. For instance, the aggregate 
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impact factor of the 19 journals in the category  ‘ primary 
health care ’ is 1.682, and the median impact factor is 
1.295. 
 Besides the formula, the characteristics of the jour-
nal itself inﬂ uence the JIF. Many journals with a high JIF 
are American. The  British Journal of General Practice had 
to hand over its lead in the JIF ranking to the American 
 Annals of Family Medicine very soon after the launch 
of that journal. Also, journals in languages other than 
English, in general, have lower JIFs. High impact journals 
also cover the  ‘ right ’ research ﬁ eld: the highest impact 
factor for family medicine is 5.4, for oncology it is 115.8, 
a 21-fold diﬀ erence. Furthermore, they favour to publish 
reviews, which are cited more often, but by nature sel-
dom cover pioneering research. Finally, journals covering 
basic science have an advantage over journals covering 
clinical science: clinical papers will often need to cite 
fundamental research, but biomedical research articles 
will less readily cite clinical papers (2). 
 Therefore, the JIF is far from perfect as an indicator 
of a journal ’ s impact on science. It probably owes its 
popularity to the fact that it is just one simple number 
with an appealing name. Its simplicity may easily deceive 
us. Moreover,  ‘ impact ’ has many other dimensions than 
scientiﬁ c. The ultimate aim of primary care research is 
to improve outcomes for people living in the community, 
so why not also consider  ‘ societal impact. ’ More recently 
this dimension has gained some momentum modelled 
on the Research Excellence Framework (http://www.
ref.ac.uk/) in the UK or the EU ’ s U-Multirank (http://
www.beltanenetwork.org/event/impact-of-science-
conference/). 
 The limitations of the JIF would in fact not matter too 
much if it were just a competitive game among journals 
motivating authors and editors to do their best. How-
ever, despite the drive for innovation in this ﬁ eld, univer-
sity managers and governmental (funding) bodies still 
judge researchers and research groups on the impact 
factor of the journals in which they publish. This modern 
use of the impact factor is — we cite  ‘ Nature, ’ a very high 
impact journal — no less than a  ‘ mortal sin ‘ (6). Recently, 
pleas for alternative ways of assessing the quality of 
research have been launched, such as the Leiden Mani-
festo (7). 
 All this being said, a higher impact factor is good 
news for any journal because — whichever way you look 
at it — it means that more researchers are using the jour-
nal and ﬁ nd it worthwhile to cite its articles. This is a 
compliment to the authors and reviewers and everyone 
who has made this possible. However, in the meantime 
we all should be aware that this crude and easily count-
able measure — that may be diﬀ erent next year — is not 
a comprehensive measure of the  ‘ real ’ impact of a jour-
nal. A journal ’ s ambition should go beyond being cited. 
It should aim to have an impact on clinical practice, 
health policy and ultimately on society. 
 The articles in this issue are a ﬁ ne illustration of the 
diﬀ erent kinds of possible impacts: e.g. there is a scien-
tiﬁ c analysis of the diagnostic value of a laboratory test 
(Willemsen et  al.), two studies concerning common clin-
ical problems (Leclercq et  al.; Nijrolder et  al.), a study on 
education (Vrdoljak et  al.) and ﬁ nally a review on the 
quality of healthcare for people with multimorbidity, 
which concerns healthcare policy (Ricci-Cabello et  al.). 
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